A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19208430

Cancer 2009 Apr 15 115 8 1713-22

Download in:

View as

Triples

General Info

PMID
19208430